Trial Search
Current Search Criteria:
A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus Who Are Currently on Metformin Monotherapy
PHASE2This is a multicenter, randomized, placebo-controlled, double-blind, Phase ...
Status
Completed
Location
ConjuChem Biotechnologies Inc.
Start Date
2008-02
Trial ID
NCT00638716
Treatments Being Tested
A Study of CJC-1134-PC Injection in Antidiabetic Treatment-naive Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control
PHASE3This study is a Multicenter, Randomized, Double-blind, Placebo-controlled P...
Status
Completed
Location
Peking University People's Hospital
Start Date
2021-04-16
Trial ID
NCT07058545
Treatments Being Tested
Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy
PHASE2DM200-103 is a dose-ranging study to evaluate the efficacy and safety of 17...
Status
Terminated
Location
Research Site
Start Date
2011-09
Trial ID
NCT01514149
Treatments Being Tested
A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Who Are Currently on Metformin Monotherapy
PHASE2This is a multicenter, randomized, placebo-controlled, double-blind, Phase ...
Status
Completed
Location
Maggie Wang
Start Date
2008-03
Trial ID
NCT00674466
Treatments Being Tested
A Study of CJC-1134-PC Injection in Patients With Type 2 Diabetes With Inadequately Controlled Blood Glucose Level After Metformin Monotherapy or Metformin in Combination With Insulin Secretagogues
PHASE3This study is a Multicenter, Randomized, Double-blind, Placebo-controlled P...
Status
Completed
Location
Peking University People's Hospital
Start Date
2021-05-27
Trial ID
NCT07057271
Treatments Being Tested